Trials / Completed
CompletedNCT04749017
The Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience
A Double Blind, Randomized, Controlled Study for the Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Universidad Católica San Antonio de Murcia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the potential effect of Avena Sativa L. on wellbeing during smoking reduction/cessation
Detailed description
The duration of the study will be 90 days (12 weeks). The consumption time will be set at 60 days (8 weeks), the remaining 30 days will be for follow up, the product will not be consumed. Each day of the study will be recorded in a diary by each subject. Subjects are randomized based on the number of cigarettes and the Richmond test. In addition, subjects with a high score on the DASS-21 test items could not participate in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Experimental product consumption | Consumption of the experimental product 2 capsules daily, morning and evening (450 mg each capsule) for 60 days |
| OTHER | Control product consumption | Consumption of control product of identical appearance 2 capsules daily for 60 days, morning and evening |
Timeline
- Start date
- 2021-01-20
- Primary completion
- 2021-07-30
- Completion
- 2021-12-31
- First posted
- 2021-02-10
- Last updated
- 2022-02-15
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04749017. Inclusion in this directory is not an endorsement.